Skip To Main Content
Brian Hill on Muck Rack

Brian Hill

  • Communications Associate, GoFundMe
  • Communications Associate, GoFundMe
Atlanta
As seen in: Medium, Nature, Aol, Ars Technica, Scotland on Sunday, Daily Herald, The Oklahoman, WFLD-TV (Chicago, IL), WJBK-TV (Detroit, MI), WNYW-TV (New York, NY) and
Storyteller • @gofundme Communications Manager • @VCU Alum • VA Native • Traveler • Formerly: @FOX5Atlanta @WTKR3 @WJHG_TV @8News
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Brian

Contact Brian, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton’s tyrosine kinase inhibitor therapy

|
By Yucai Wang, Melissa Larson, Steven Hwang, Diego Villa, Laveniya Kugathasan, Anita Kumar Verified, Ashlee Joseph, Taylor Brooks, Brian Hill, David Bond, Kami J. Maddocks, Alexey B. Danilov, Jia Ruan, Imran Nizamuddin, Brad S. Kahl, Natalie Grover Verified, Georgios Pongas, Izidore S. Lossos, Evguenia Ouchveridze, Aung M. Tun, Firas Baidoun, Muhamad Alhaj Moustafa, Zoey Harris, Javier Muñoz, Philip Young, Craig Portell, Patrick M Reagan, Christine Ryan, Reid W. Merryman, Arash Velayati, Drew Gerber, Preetesh Jain, Michael Wang, Eric Mou, Lauren G. Banaszak, Priyanka A. Pophali, Anthony Stack, Marcus Messmer, Mayur Narkhede, Amitkumar Mehta, Nilanjan Ghosh, Rahul S Bhansali, Stefan K. Barta, Manali K. Kamdar, Jacob L. Anna, Reem Karmali, Matthew J. Maurer, James R. Cerhan, Jonathon Cohen, Peter Martin, Christine Argao, Nazneen B. Khan, I. Brian Greenwell, Sabarish R. Ayyappan, Tamara K. Moyo, Alexander V. Stanisic
| Nature Verified
Abstract Addition of Bruton’s tyrosine kinase inhibitor (BTKi) to first-line (1 L) bendamustine-rituximab (BR) improved progression-free survival (PFS) in patients with mantle cell lymphoma (MCL) in the SHINE and ECHO trials. We investigated whether sequential treatment with 1 L BR and second-line (2 L) BTKi can result in similar cumulative PFS compared to BR-BTKi combination therapy, using a multicenter cohort of 755 patients treated with 1 L BR between 2014 and 2020.
Open in Who Shared Issue with article?

When vision meets persistence: D51 reaches historic milestone

|
By Brian Hill
| Grand Junction Daily Sentinel Verified
A little over three years ago, a simple but powerful question brought a room full of District 51 educators, families, leaders, and community members together: What kind of future do we want for our students in Mesa County? With the support of the Colorado Education Initiative, we worked side by side to define a clear vision and set bold three-year goals for learning and growth.
Open in Who Shared Issue with article?

When will the people wake up?

|
By Brian Hill
| Skagit Valley Herald Verified
How long is it going to be before the people of what was at one time the greatest country in the world wake up and see exactly what your president is doing to a country that is quickly sliding into second world status? I suppose that a better question would be, exactly what is it going to take for the people of this country to wake up and see exactly what your president and the Republican Party are doing to this formerly great country?
Open in Who Shared Issue with article?
See all 1,020 licensed articles (1,025 Total)